Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,281 | 696 | 91.5% |
| Travel and Lodging | $1,122 | 5 | 8.4% |
| Education | $19.47 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $2,485 | 69 | $0 (2024) |
| Boston Scientific Corporation | $2,070 | 110 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,865 | 113 | $0 (2020) |
| Abbott Laboratories | $929.47 | 57 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $928.43 | 60 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $918.75 | 58 | $0 (2024) |
| Amgen Inc. | $765.41 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $711.87 | 48 | $0 (2023) |
| PFIZER INC. | $426.87 | 27 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $359.11 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,825 | 119 | Novartis Pharmaceuticals Corporation ($455.69) |
| 2023 | $1,378 | 76 | Boston Scientific Corporation ($560.35) |
| 2022 | $941.41 | 33 | Medtronic, Inc. ($266.86) |
| 2021 | $2,466 | 66 | Medtronic, Inc. ($1,726) |
| 2020 | $721.26 | 40 | Medtronic Vascular, Inc. ($316.73) |
| 2019 | $1,400 | 90 | Boston Scientific Corporation ($236.59) |
| 2018 | $2,226 | 132 | Medtronic Vascular, Inc. ($574.26) |
| 2017 | $2,465 | 148 | Medtronic Vascular, Inc. ($787.44) |
All Payment Transactions
704 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/17/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Pacemakers | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.66 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: ACCOLADE_CRM | ||||||
| 12/11/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: LUX-Dx_CRM | ||||||
| 12/05/2024 | Boston Scientific Corporation | LATITUDE Communicator Power Supply (Device) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: LATITUDE_CRM | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $35.29 | General |
| Category: DEVICES | ||||||
| 11/14/2024 | Boston Scientific Corporation | myLUX Patient Kit with mobile device (Device) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: myLUX_CRM | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: LUX-Dx_CRM | ||||||
| 11/04/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: Cardiovascular | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: General - Therapies_CRM | ||||||
| 10/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/19/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $148.91 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.91 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 6,940 | 9,799 | $3.0M | $713,822 |
| 2022 | 44 | 6,520 | 9,000 | $2.5M | $621,472 |
| 2021 | 37 | 5,953 | 8,166 | $1.7M | $473,655 |
| 2020 | 37 | 4,544 | 5,758 | $1.3M | $328,071 |
All Medicare Procedures & Services
166 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 662 | 1,012 | $405,812 | $128,504 | 31.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 389 | 389 | $455,005 | $106,826 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 949 | 1,174 | $349,852 | $98,513 | 28.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 722 | 739 | $543,165 | $93,693 | 17.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 264 | 264 | $151,272 | $41,095 | 27.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 190 | 380 | $104,880 | $33,523 | 32.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 158 | 632 | $97,960 | $26,716 | 27.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 131 | 262 | $111,874 | $24,294 | 21.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,479 | 2,040 | $118,320 | $20,400 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 138 | 138 | $62,928 | $15,874 | 25.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 295 | 308 | $63,140 | $15,689 | 24.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 323 | 323 | $87,856 | $15,149 | 17.2% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 24 | 24 | $35,520 | $9,382 | 26.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 57 | 57 | $43,662 | $8,223 | 18.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 71 | 412 | $33,372 | $7,840 | 23.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 161 | 352 | $35,200 | $7,639 | 21.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 70 | 89 | $32,218 | $7,283 | 22.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 34 | 34 | $31,280 | $7,062 | 22.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 67 | 68 | $25,840 | $6,501 | 25.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 144 | 234 | $27,612 | $6,059 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 112 | $22,823 | $5,910 | 25.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 36 | 36 | $25,236 | $4,853 | 19.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 41 | 47 | $14,805 | $3,828 | 25.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 42 | 196 | $14,504 | $3,791 | 26.1% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 13 | 13 | $13,286 | $3,290 | 24.8% |
About Dr. John Sharp, MD
Dr. John Sharp, MD is a Cardiovascular Disease healthcare provider based in Hilton Head Island, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780673830.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sharp, MD has received a total of $13,422 in payments from pharmaceutical and medical device companies, with $1,825 received in 2024. These payments were reported across 704 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($12,281).
As a Medicare-enrolled provider, Sharp has provided services to 23,957 Medicare beneficiaries, totaling 32,723 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 166 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Hilton Head Island, SC
- Active Since 10/20/2005
- Last Updated 08/09/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1780673830
Products in Payments
- Micra (Device) $2,010
- ELIQUIS (Drug) $909.13
- XARELTO (Drug) $711.87
- ENTRESTO (Drug) $598.35
- Repatha (Biological) $500.08
- MICRA (Device) $433.32
- LUX-Dx Insertable Cardiac Monitor (Device) $340.37
- LEQVIO (Drug) $330.08
- CHANTIX (Drug) $312.13
- WATCHMAN Access System (Device) $296.37
- PRADAXA (Drug) $290.47
- WATCHMAN FLX (Device) $268.42
- Corlanor (Drug) $265.33
- Reveal LINQ (Device) $262.69
- Claria MRI (Device) $232.27
- WATCHMAN (Device) $232.21
- Azure (Device) $219.45
- CONFIRM RX (Device) $201.87
- LifeVest (Device) $199.08
- BRILINTA (Drug) $195.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.